TickerFacts.

China SXT Pharmaceuticals, Inc. (SXTC): R&D Expense

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest R&D Expense is for the year ended 2024-03-31, while the company's latest annual report covers the year ended 2026-03-31. Its later filings do not report this line under the concept TickerFacts maps.

$184.2K
Year ended 2024-03-31
$367.0K2022-03-31: $367.0K2023-03-31: $200.7K2024-03-31: $184.2K$184.2K
2022-03-31 R&D Expense (USD) 2024-03-31
Period endedR&D ExpenseChange YoYSource filing
2024-03-31$184.2K-8.2%2024-08-13, From 2023-04-01
2023-03-31$200.7K-45.3%2024-08-13, From 2022-04-01
2022-03-31$367.0Kn/a2024-08-13, From 2021-04-01